• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国糖尿病协会与青少年糖尿病研究基金会研究研讨会:糖尿病与微生物组

American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome.

作者信息

Semenkovich Clay F, Danska Jayne, Darsow Tamara, Dunne Jessica L, Huttenhower Curtis, Insel Richard A, McElvaine Allison T, Ratner Robert E, Shuldiner Alan R, Blaser Martin J

机构信息

Washington University School of Medicine, St. Louis, MO.

The Hospital for Sick Children, Toronto, Canada.

出版信息

Diabetes. 2015 Dec;64(12):3967-77. doi: 10.2337/db15-0597. Epub 2015 Sep 29.

DOI:10.2337/db15-0597
PMID:26420863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4876761/
Abstract

From 27-29 October 2014, more than 100 people gathered in Chicago, IL, to participate in a research symposium titled "Diabetes and the Microbiome," jointly sponsored by the American Diabetes Association and JDRF. The conference brought together international scholars and trainees from multiple disciplines, including microbiology, bioinformatics, endocrinology, metabolism, and immunology, to share the current understanding of host-microbe interactions and their influences on diabetes and metabolism. Notably, this gathering was the first to assemble specialists with distinct expertise in type 1 diabetes, type 2 diabetes, immunology, and microbiology with the goal of discussing and defining potential pathophysiologies linking the microbiome and diabetes. In addition to reviewing existing evidence in the field, speakers presented their own original research to provide a comprehensive view of the current understanding of the topics under discussion.Presentations and discussions throughout the conference reflected a number of important concepts. The microbiota in any host represent a complex ecosystem with a high degree of interindividual variability. Different microbial communities, comprising bacteria, archaea, viruses, and fungi, occupy separate niches in and on the human body. Individually and collectively, these microbes provide benefits to the host-including nutrient harvest from food and protection against pathogens. They are dynamically regulated by both host genes and the environment, and they critically influence both physiology and lifelong health. The objective of the symposium was to discuss the relationship between the host and the microbiome-the combination of microbiota and their biomolecular environment and ecology-specifically with regard to metabolic and immunological systems and to define the critical research needed to understand and potentially target the microbiome in the prevention and treatment of diabetes. In this report, we present meeting highlights in the following areas: 1) relationships between diabetes and the microbiome, 2) bioinformatic tools, resources, and study design considerations, 3) microbial programming of the immune system, 4) the microbiome and energy balance, 5) interventions, and 6) limitations, unanswered questions, and resource and policy needs.

摘要

2014年10月27日至29日,100多人齐聚伊利诺伊州芝加哥市,参加由美国糖尿病协会和青少年糖尿病研究基金会联合主办的题为“糖尿病与微生物群”的研究研讨会。会议汇聚了来自微生物学、生物信息学、内分泌学、代谢学和免疫学等多个学科的国际学者和学员,以分享对宿主-微生物相互作用及其对糖尿病和代谢影响的当前认识。值得注意的是,这次会议首次召集了在1型糖尿病、2型糖尿病、免疫学和微生物学方面具有独特专业知识的专家,旨在讨论和确定将微生物群与糖尿病联系起来的潜在病理生理学。除了回顾该领域的现有证据外,发言者还展示了他们自己的原创研究,以全面呈现对所讨论主题的当前理解。会议期间的演讲和讨论反映了一些重要概念。任何宿主中的微生物群代表一个具有高度个体间变异性的复杂生态系统。由细菌、古菌、病毒和真菌组成的不同微生物群落占据人体内外不同的生态位。这些微生物个体和集体地为宿主提供益处,包括从食物中获取营养和抵御病原体。它们受到宿主基因和环境的动态调节,并对生理学和终身健康产生关键影响。研讨会的目的是讨论宿主与微生物群(微生物群及其生物分子环境和生态的组合)之间的关系,特别是关于代谢和免疫系统,并确定在糖尿病的预防和治疗中理解和潜在靶向微生物群所需的关键研究。在本报告中,我们展示了以下领域的会议亮点:1)糖尿病与微生物群之间的关系,2)生物信息学工具、资源和研究设计考虑因素,3)免疫系统的微生物编程,4)微生物群与能量平衡,5)干预措施,以及6)局限性、未解决的问题以及资源和政策需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d5/4876761/245408ae206c/db150597f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d5/4876761/ed2fd7bc069d/db150597f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d5/4876761/9a9ec387e927/db150597f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d5/4876761/245408ae206c/db150597f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d5/4876761/ed2fd7bc069d/db150597f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d5/4876761/9a9ec387e927/db150597f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07d5/4876761/245408ae206c/db150597f3.jpg

相似文献

1
American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome.美国糖尿病协会与青少年糖尿病研究基金会研究研讨会:糖尿病与微生物组
Diabetes. 2015 Dec;64(12):3967-77. doi: 10.2337/db15-0597. Epub 2015 Sep 29.
2
Targeting gut microbiota as a possible therapy for diabetes.将肠道微生物群作为糖尿病的一种可能治疗方法。
Nutr Res. 2015 May;35(5):361-7. doi: 10.1016/j.nutres.2015.03.002. Epub 2015 Mar 14.
3
Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome.肠道微生物群对1型和2型糖尿病风险的调节作用。
Pediatr Diabetes. 2016 Nov;17(7):469-477. doi: 10.1111/pedi.12424. Epub 2016 Aug 3.
4
New therapies for diabetes management.糖尿病管理的新疗法。
Diabetes Technol Ther. 2013 Feb;15 Suppl 1:S126-35. doi: 10.1089/dia.2013.1514.
5
Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.根据病理生理学、自然病史和预后对糖尿病进行区分。
Diabetes. 2017 Feb;66(2):241-255. doi: 10.2337/db16-0806. Epub 2016 Dec 15.
6
Gut microbiota and immunopathogenesis of diabetes mellitus type 1 and 2.肠道微生物群与 1 型和 2 型糖尿病的免疫发病机制。
Front Biosci (Landmark Ed). 2016 Jun 1;21(5):900-6. doi: 10.2741/4427.
7
Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.益生元纤维(低聚半乳糖)摄入后人体2型糖尿病中的宿主-微生物组相互作用。
Br J Nutr. 2016 Dec;116(11):1869-1877. doi: 10.1017/S0007114516004086. Epub 2016 Dec 15.
8
Microbiome-MX 2018: microbiota and microbiome opportunities in Mexico, a megadiverse country.2018 年墨西哥微生物组大会:在这个生物多样性大国,探讨微生物组和微生物群的机遇。
Res Microbiol. 2019 Jun-Aug;170(4-5):235-241. doi: 10.1016/j.resmic.2019.03.001. Epub 2019 Mar 25.
9
Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes.家族性 1 型糖尿病病例研究中的人类肠道微生物组的综合多组学研究。
Nat Microbiol. 2016 Oct 10;2:16180. doi: 10.1038/nmicrobiol.2016.180.
10
ISPAD Clinical Practice Consensus Guidelines 2014. Other complications and diabetes-associated conditions in children and adolescents.《国际儿童青少年糖尿病研究学会(ISPAD)2014年临床实践共识指南:儿童和青少年的其他并发症及糖尿病相关病症》
Pediatr Diabetes. 2014 Sep;15 Suppl 20:270-8. doi: 10.1111/pedi.12183.

引用本文的文献

1
Quantitative Analysis and Visualization of the Interaction Between Intestinal Microbiota and Type 1 Diabetes in Children Based on Multi-Databases.基于多数据库的儿童肠道微生物群与1型糖尿病相互作用的定量分析与可视化
Front Pediatr. 2021 Dec 15;9:752250. doi: 10.3389/fped.2021.752250. eCollection 2021.
2
Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges.1 型糖尿病对儿童和青少年肠道微生物组组成和功能潜力的影响:可能的机制、现有知识和挑战。
Gut Microbes. 2021 Jan-Dec;13(1):1-18. doi: 10.1080/19490976.2021.1926841.
3

本文引用的文献

1
Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.早期使用抗生素会改变肠道微生物群,并增加自身免疫性胰岛素依赖型糖尿病自发小鼠模型中的疾病发生率。
PLoS One. 2015 May 13;10(5):e0125448. doi: 10.1371/journal.pone.0125448. eCollection 2015.
2
The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes.人类婴儿肠道微生物群在发育过程中以及向1型糖尿病发展过程中的动态变化。
Cell Host Microbe. 2015 Feb 11;17(2):260-73. doi: 10.1016/j.chom.2015.01.001. Epub 2015 Feb 5.
3
Gut microbiota. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation.
Analysis of the Gut Mycobiome in Adult Patients with Type 1 and Type 2 Diabetes Using Next-Generation Sequencing (NGS) with Increased Sensitivity-Pilot Study.
使用高灵敏度下一代测序(NGS)技术对1型和2型糖尿病成年患者肠道真菌群落进行分析——初步研究
Nutrients. 2021 Mar 25;13(4):1066. doi: 10.3390/nu13041066.
4
High Fat Diet Dysbiotic Mechanism of Decreased Gingival Blood Flow.高脂饮食导致牙龈血流减少的生态失调机制。
Front Physiol. 2021 Mar 3;12:625780. doi: 10.3389/fphys.2021.625780. eCollection 2021.
5
Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes.肥胖、代谢综合征和 2 型糖尿病中的镁。
Nutrients. 2021 Jan 22;13(2):320. doi: 10.3390/nu13020320.
6
Glu-mGluR2/3-ERK Signaling Regulates Apoptosis of Hippocampal Neurons in Diabetic-Depression Model Rats.谷氨酸-mGluR2/3-ERK信号通路调控糖尿病性抑郁症模型大鼠海马神经元凋亡
Evid Based Complement Alternat Med. 2019 Jun 10;2019:3710363. doi: 10.1155/2019/3710363. eCollection 2019.
7
Integrative Analysis Toward Different Glucose Tolerance-Related Gut Microbiota and Diet.不同糖耐量相关肠道微生物群与饮食的综合分析
Front Endocrinol (Lausanne). 2019 May 27;10:295. doi: 10.3389/fendo.2019.00295. eCollection 2019.
8
Determining Antigen Specificity of Human Islet Infiltrating T Cells in Type 1 Diabetes.鉴定 1 型糖尿病患者胰岛浸润 T 细胞的抗原特异性。
Front Immunol. 2019 Mar 8;10:365. doi: 10.3389/fimmu.2019.00365. eCollection 2019.
9
Role of the microbiome in human development.微生物组在人类发育中的作用。
Gut. 2019 Jun;68(6):1108-1114. doi: 10.1136/gutjnl-2018-317503. Epub 2019 Jan 22.
10
Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease.非裔美国男性糖尿病患者和慢性疾病负担较高者的肠道微生物群因阿片类药物使用、循环瘦素和催产素而有所不同。
PLoS One. 2018 Mar 29;13(3):e0194171. doi: 10.1371/journal.pone.0194171. eCollection 2018.
肠道微生物群。抗菌肽抗性介导炎症期间主要肠道共生菌的恢复力。
Science. 2015 Jan 9;347(6218):170-5. doi: 10.1126/science.1260580.
4
Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes.多雷拟杆菌在芬兰 1 型糖尿病高危儿童发生自身免疫前主导肠道微生物组。
Front Microbiol. 2014 Dec 10;5:678. doi: 10.3389/fmicb.2014.00678. eCollection 2014.
5
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.肠道法尼醇X受体信号传导促进非酒精性脂肪性肝病。
J Clin Invest. 2015 Jan;125(1):386-402. doi: 10.1172/JCI76738. Epub 2014 Dec 15.
6
Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status.肠道上皮细胞中的髓样分化因子88(MyD88)是一种传感器,可根据营养状况将宿主代谢转换为有利于肥胖的状态。
Nat Commun. 2014 Dec 5;5:5648. doi: 10.1038/ncomms6648.
7
Gut microbiota and obesity: role in aetiology and potential therapeutic target.肠道微生物群与肥胖:在病因学中的作用及潜在治疗靶点
Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):585-97. doi: 10.1016/j.bpg.2014.07.005. Epub 2014 Jul 11.
8
Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies.美国种族/民族、老龄化和体重指数趋势与糖尿病患病率之间的关联:一系列横断面研究。
Ann Intern Med. 2014 Sep 2;161(5):328-35. doi: 10.7326/M14-0286.
9
Microbial modulation of insulin sensitivity.微生物对胰岛素敏感性的调节。
Cell Metab. 2014 Nov 4;20(5):753-760. doi: 10.1016/j.cmet.2014.07.006.
10
Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice.肠道上皮细胞Toll样受体5调节肠道微生物群以预防小鼠的低度炎症和代谢综合征。
Gastroenterology. 2014 Dec;147(6):1363-77.e17. doi: 10.1053/j.gastro.2014.08.033. Epub 2014 Aug 27.